Features A - Z
View Features alphabetically- Air cargo transportation: on the right path
- A vital cog in the machine
- A good deal better: pharmaceutical mergers and acquisitions
- A visible difference: protecting the cold chain
- Analyse this – the rise of Raman spectroscopy
- A solution for poor water solubility
- A contract, not a marriage – building pharma partnerships
- A common accord – harmonised data exchange
- Adapt and thrive – understanding adaptive clinical trials
- A bitter pill to swallow – the excipient approval process
- An inspector calls – maintaining good manufacturing practices
- Ahead of the game – risk management in clinical trial supply chains
- A problem shared – utilising clinical trials data
- A fully integrated future - pharmaceutical manufacturing processes
- A new chapter – examining new cross-contamination guidelines
- Adverse reactions: drug safety
- A visible difference: clinical packaging
- All together now – harmonising clinical trial regulation
- A matter of degrees – cold chain management
- Automatic improvement – optimising manufacturing processes
- A penny saved: clinical supplies funding
- All systems are go
- Addressing the challenges of injectable biologic and wearable drugs
- Active and passive packaging solutions for ambient-temperature pharmaceuticals
- Anti-cancer collaboration
- A winning combination: digital solutions for medical treatments
- Buying niche and new businesses
- Birth of cyber-collaboration
- Behind the healthy cover of supply chain security
- Boxing clever with pharmaceutical packaging
- Better together
- Brave new world – the risks and rewards of emerging markets
- Better together - rapid sourcing of quality drugs
- Blanket decisions – hot trends in the cold chain
- Better together – working with CMOs
- Best practice: solid risk management plan
- Building confidence of pharma sector on air transport of temperature-sensitive products
- Back in the real world: power of real-world data on clinical trials
- Blind ambition: unblinded study medication for better clinical trials
- Bringing together academia’s innovation and pharma’s resources
- Battling contamination
- Crystal clear: production of co-crystals
- Cost of a deep cut
- Caught in the net with packaging protection
- Controlled-release drugs: ready for take-off
- Coming together in hard times: biotech funding
- Changing trends in early-stage clinical trials
- Cool gadgets for the cold chain
- Cut costs, not quality: outsourcing in clinical trials
- Choose wisely: selecting the right CRO
- Cool operator
- Critical factors in CRO contracting
- Cold room: mapping out the future of storage
- Common people – a single view of process data
- Contractually yours – quality contract manufacturing
- Central to success? Reliable data in trials
- Chain reaction: safety in logistics
- Check the forecast: supply challenges
- Cold hard facts of freeze-drying drugs
- Comparator wisdom – analysing comparator sourcing
- Cold comfort - Cloud-based temperature-monitoring solutions
- Collaboratively speaking – comparator supply
- Combined effort – launching combination products
- Cold chain challenge
- Continuous manufacturing can improve quality in pharmaceutical industry
- Connected health services and smart device solutions
- Communicating clinical trial results effectively can improve public trust
- Check the small print: smart-labelling
- Calculating risk
- Combinational pride: the complexity of mixing drugs, devices and biologics
- Delivering the goods: drug delivery in a competitive market
- Dangerous liaisons
- Drug trials: publish and be damned
- Digital leap into the pharmaceutical production line
- Designs on packaging sustainability
- Diagnosis merger – examining the mega M&A trend
- Digitally speaking – the future of pharmaceutical R&D
- Don’t skimp on quality – maximising quality to reduce costs
- Design on trial – immune-oncology challenges
- Data control in the clinical trials cold chain
- Dispersion: advancing drug delivery
- Digital trailblazers
- Eastern Europe comes in from the cold
- eCDT’s benefit performance
- Emerging markets come in from the cold
- Excipients: pharma’s silent partners
- Erase rubber risk
- eCTD submissions made simple
- Elegant simplicity – single-dose disposable inhalers
- Eastern promise - the Chinese pharmas’ market
- Extreme measures – a robust vaccine supply chain
- Energise the chain – Harvey Rubin
- Excellence in cargo transport
- Embracing injectables and wearables
- Ensuring drug safety during clinical trials
- Follow the leader: biopharma growth in Latin America
- Focus on your recruitment practices
- Future perfect: identity security in global collaboration
- Future perfect – reshaping supply chain strategy
- Final analysis - strategies for POC trials
- Freight expectations – GDP guidelines and the CEIV Pharma programme
- False moves – purging the market of counterfeit drugs
- From molecule to medicine - peptide and protein drugs
- Follow the trail to forgery – supply chain safety
- Freedom of choice – choosing the correct vendor
- Fail to plan, plan to fail – the timely delivery of drug supply
- Find your balance – bridging internal capacity gaps
- Front and centre: handling complexities of clinical trials
- Forward together: combining the forces of academia and pharma
- Favourable comparisons: comparators and the pharma industry
- Face up to failure: improving the strike rate of clinical trials
- Forward together: CDMOs
- Got your number: combating counterfeiting across Europe
- Get on board – transporting pharmaceuticals by sea
- Greener sleeves – packaging sustainability in the pharma sector
- Get the programme started – cost-effective supply chain security
- Get smart – next-generation pharmaceutical packaging
- Great expectations in new excipients
- Go the extra mile – shipment temperature monitoring
- Getting the writing right: importance of medical writing
- Getting ready for serialisation: 'track and trace' solutions
- Identity trust in cyberspace
- In close contract – the risks and rewards of outsourcing
- Ingredients for success – challenges facing API manufacturers
- Importance of clinical trial transparency
- Integrated data management can cut down trial cost
- Improving design of pre-clinical models for better outcome in clinical trials
- Lethal injection: the issues in sterility assurance
- Let the right one in – outsourcing biological medicines
- Logistical nightmare - Delivering temperature-sensitive air freight
- Lipid-based suspension can unlock new horizons in oral bioavailability
- Let’s be clear: transparency and disclosure of clinical trials
- New recruits: Cancer Research UK
- Necessary change – perfecting process-analytical technology
- New mechanics of quality control – bringing medicines to market
- Nothing to hide – medical writing and trial records
- Night moves – maintaining supply chain standards
- Name and number
- Needles: soon to be obsolete?
- Overcoming obstacles in pharmaceutical research
- Off the shelf: analysing drug stability data
- Optimal planning for clinical supply
- Outsourcing manufacturing: change is the only constant
- Online application
- Open relationship – the importance of post-trial reviews
- Organisation is key: factors involved in the clinical trial life cycle
- Out cold: developments in pharma cold chain
- Out in the cold chain
- Push for paperless clinical trials
- Partnerships that ease pain
- Pharma’s emerging markets
- Pharma deals on the rise
- Pharma’s emerging focus
- Play it cool in the pharma cold chain
- Pharmaceutical outsourcing: building a model
- Pharma cold chain: a calculated risk
- Positive reaction: public opinion of adjuvants
- Picture perfect: imaging in therapeutic drug development
- Privacy vs progress: patient confidentiality in personalised medicine
- Pep talk
- Pack mentality – clinical trial packaging
- Problem dissolved? – ensuring improved bioavailability
- Pep talk – manufacturing peptide tablets
- Patient approach – tailoring therapies to individual needs
- Power of OTC drugs – the over-the-counter revolution
- Pharma industry must unite in fight against cybercrime
- Print your own medicine – the evolution of 3D printing
- Profitable packaging – reducing cost without compromising quality
- Phone it in – Roma Maguire discusses the eSMART study
- Protected links – safeguarding the supply chain
- Power tools – biomedical informatics
- Partners on the front lines – emergency planning and collaboration
- Personalised supply chain – the changing face of clinical trials
- Pack to the future – medical packaging for the elderly
- Put patients first – increasing awareness of clinical trials
- Parenteral control - challenges of formulating novel excipients
- Prevention of temperature deviation in the pharma packaging
- Procurement process automation necessary for pharma firms
- Platform for success: Integrated data management platform for clinical trials
- Power of real-world data in clinical trials
- Play a role: clinical trials in China
- Packing heat: temperature control during storage and distribution
- Race to the top
- Riding pharma’s R&D rollercoaster
- Risk and reward: tools and metrics for identifying and monitoring risk in clinical trials
- Rules of engagement - redefining the sponsor-CRO relationship
- Raw recruit – the importance of human capital
- Remember the reader: importance of clinical trial transparency
- Rules of engagement: patient-centricity and patient management
- Room for improvement: cold-chain pharmaceuticals
- Sustainable growth: pharma goes green
- Small impact, big rewards: global pharma vs climate change
- Sourcing comparator drugs: the tactical approach
- Suspended solutions for solubility
- Shaping the future of clinical data management
- Spread too thin?
- Special drug delivery
- Slow and steady wins the race
- Scaling the pharmaceutical patent cliff
- Space to grow – treating Type 2 diabetes
- Stop, thief! – pharmaceutical shipment security
- Safe trip – standardising insulated shipping containers
- Safety conscious – the role of RMPs in pharmacovigilance
- Same difference: biosimilars market growth
- Smart thinking: data management
- Second chance saloon - the sale of unused comparators
- Socially adverse – inside the Web-RADR project
- Swap the runway for the waves – the ocean-going supply chain
- Small companies with big perks
- Safe and stable – the importance of stability data
- Supply-chain lockdown – serialisation regulation
- Second skin – wearable drug delivery
- Sticky problem: challenges of proper packaging and labelling of clinical supplies
- Sharing is caring: communication among clinical trial companies
- Safe passage: data control in the clinical trials cold chain
- Safety fast: ensuring drug safety during clinical trials
- Similar experiences: challenges involved with biosimilars
- Supply chain challenges before biosimilars
- Securing the supply chain
- Sourcing on a global scale
- Sweet harmony: clinical trials protocol template
- Silver linings:cloud-based technology for clinical trials
- Safely delivering the goods: a successful supply chain
- The cold chain: ensuring a smooth ride
- Top ten global pharma
- Top ten generic pharma
- Top ten generic companies
- Take five: significant pharma industry deals in Q2/Q3
- The changing role of the data manager
- The cost of creativity
- The complete guide through the pharma product chain
- The game changers: WPF awards 2013
- The strongest link: ensuring product security in the supply chain
- The growing case for reusable packaging
- The need for lean
- Time to act – challenging packaging conventions
- Tracked and traced – end-to-end supply chain visibility
- Turn the page – electronic PROs
- The chill factor – cold chain strategies
- The tactical game of comparators - logistical and regulatory hurdles
- The new administration – prefilled syringes and auto-injectors
- The rewards of risk management – de-risking globalised supply chains
- The sky’s the limit – cloud computing for clinical trials
- Track changes – serialisation best practice
- Third-party people – alternatives to the contract manufacturing model
- The necessity of quality control – examining CRT technology
- Tipping point – point-of-care diagnostics
- The bottom line – the global therapeutics market for irritable bowel syndrome
- The dust disruption – ensuring sterile clean rooms
- The human factor – pharmaceutical packaging
- The cost of new cures – inside the NCE market
- Take a deep breath – inhalable drug delivery
- Third-party people – collaborative diabetes drug development
- The importance of being compliant – packaging and labelling processes
- The devil’s in the data – clinical data integration
- The new cool – the changing face of pharma transportation
- The future is biological - high-concentration liquid formulations
- The changing face of product identity
- The sprinkle formula – the viability of minitablets
- The quicker the better – air freight and temperature control
- Tracking all over the world – serialising medical products
- Through wind, snow and heat
- Time to embrace a new production process
- Temperature monitoring during drug transport and storage
- Tamper-proof barcodes to remove counterfeit drugs from supply chain
- Trials and tribulations of clinical trial life cycle
- The indefinite particle
- The analytics angle
- The power of cannabinoids
- The changing face of oral medicines
- The legal matter: controlled substances
- Trial separation: Brexit effect on pharma
- Up to the marker: clinical trial design
- Unlock innovation in logistics – streamlining the supply chain
- Using chemicals to crack down on counterfeit drugs
- Unique device identifiers for medical equipment
- Using chemical tesging to track and trace counterfeit drugs
- Unblinded study medication for better clinical trials
- Understanding excipients
- Why wholesalers need to run a tight ship
- What is an adaptive clinical trial?
- World Pharmaceutical Frontiers digital magazine
- What it says on the tin - multilingual packaging
- Waste not, want not: enhancing clinical trial supply chain efficiency
- With data in mind: best practice clinical trials management
